NOMAN THANWY: Open Payments
NPI 1659360469 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 7 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $58 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| TMS NeuroHealth Centers Inc. | 1 | $15 |
Products named: CAPLYTA, Ohtuvayre, ELIQUIS, MOUNJARO, AIRSUPRA, GVOKE HYPOPEN, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
